John Miller
Novo Nordisk, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Effectiveness and safety of starting insulin aspart premix therapy from different oral agents in routine clinical practice (#371)
2:00 PM
John Miller
ADS Clinical Poster Discussions